Published in Gene Therapy Weekly, May 3rd, 1999
Achieving protection with this vaccine, made with harmless components from a SHIV - a blend of parts from HIV and SIV (simian immunodeficiency virus) - is a step toward the development of an effective AIDS vaccine.
The study results are reported in the May 1999 issue of Nature Medicine by Dr. Harriet Robinson, chief of Microbiology and Immunology at Yerkes Primate Center.
In a three-year study, Robinson compared combinations of three different vaccine approaches and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.